经皮冠状动脉介入治疗患者微粒通过解偶联内皮型一氧化氮合酶损害血管舒张功能
研究纳入急性心肌梗死患者38例(经皮冠状动脉介入治疗术前及术后24小时取血)和健康受试者20例,用流式细胞术检测微粒来源,并用大鼠胸主动脉与微粒共孵育,评估微粒对内皮型一氧化氮合酶磷酸化、小窝蛋白-1表达、内皮型一氧化氮合酶与热休克蛋白90结合、一氧化氮和超氧阴离子生成及内皮依赖性血管舒张的影响。与健康受试者相比,急性心肌梗死患者微粒浓度升高;经皮冠状动脉介入治疗未进一步改变微粒浓度,但增加内皮来源微粒比例、降低血小板来源微粒比例。急性心肌梗死患者微粒降低内皮型一氧化氮合酶Ser1177磷酸化、增加T495磷酸化和小窝蛋白-1表达、减少内皮型一氧化氮合酶与热休克蛋白90结合、减少一氧化氮生成但增加超氧阴离子生成、损害内皮依赖性血管舒张;经皮冠状动脉介入治疗后上述效应均增强。结论认为经皮冠状动脉介入治疗进一步增强微粒的血管损伤效应,循环微粒可能是经皮冠状动脉介入治疗患者的潜在治疗靶点。
要点
- 急性心肌梗死患者(n=38)循环微粒浓度高于健康受试者(n=20)。
- 经皮冠状动脉介入治疗未进一步改变微粒浓度,但增加内皮来源微粒比例、降低血小板来源微粒比例。
- 急性心肌梗死患者微粒降低内皮型一氧化氮合酶Ser1177磷酸化、增加T495磷酸化和小窝蛋白-1表达,减少内皮型一氧化氮合酶与热休克蛋白90结合。
- 急性心肌梗死患者微粒减少一氧化氮生成、增加超氧阴离子生成并损害内皮依赖性血管舒张,经皮冠状动脉介入治疗后上述效应均增强。
- 作者认为循环微粒可能是经皮冠状动脉介入治疗患者的潜在治疗靶点。
适用人群与场景
- 急性心肌梗死患者(n=38),在经皮冠状动脉介入治疗术前及术后24小时取血;健康受试者(n=20)作对照。
- 体外实验使用大鼠胸主动脉与微粒共孵育。
研究设计与关键结果
- 研究类型为体外实验联合临床样本观察;急性心肌梗死患者38例、健康受试者20例。
- 与健康受试者相比,急性心肌梗死患者微粒浓度升高;经皮冠状动脉介入治疗未进一步改变微粒浓度,但增加内皮来源微粒比例、降低血小板来源微粒比例。
- 急性心肌梗死患者微粒降低内皮型一氧化氮合酶Ser1177磷酸化、增加T495磷酸化和小窝蛋白-1表达,减少内皮型一氧化氮合酶与热休克蛋白90结合。
- 急性心肌梗死患者微粒减少一氧化氮生成但增加超氧阴离子生成,损害内皮依赖性血管舒张。
- 经皮冠状动脉介入治疗增强上述微粒的全部血管损伤效应。
证据类型、等级与局限
- 证据类型:体外实验联合临床样本观察。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为循环微粒可能是经皮冠状动脉介入治疗患者的潜在治疗靶点。
- 原文未据此给出急诊或重症监护实践推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Percutaneous coronary interventions (PCIs) save countless acute myocardial infarction (AMI) patients. However, endothelial injury is still an inevitable complication. Circulating microparticles (MPs) play important roles in vascular dysfunction. Whether PCI affects function of MPs remains unclear.
METHODS: MPs were obtained from AMI patients (n = 38) both preoperatively and 24 h after PCI, and healthy subjects (n = 20). MPs origins were tested by flow cytometry. Rat thoracic aortas were incubated with MPs to determine the effects of MPs on phosphorylation of endothelial nitric oxide synthase (eNOS), caveolin-1 expression, eNOS association with heat shock protein 90 (Hsp90), generation of nitric oxide (NO) and superoxide anion (O2), and endothelial-dependent vasodilatation.
RESULTS: Compared with healthy subjects, MP concentrations increased in AMI patients. Undergoing PCI had no further effect on MPs concentration, but it results in increased endothelial-derived MPs proportion and decreased platelet-derived MP ratio. MPs from AMI patients decreased eNOS phosphorylation at Ser1177, increased eNOS phosphorylation at T495 and caveolin-1 expression, decreased eNOS association with Hsp90, decreased NO production but increased (O2) generation, damaged endothelial-dependent vasodilatation. All of these effects of MPs were strengthened by PCI.
CONCLUSIONS: PCI further enhances the vascular injury effect of MPs. Circulating MPs may be a potential therapeutic target for patients undergoing PCI.
参考来源
- Ye S, Shan XF, Han WQ, et al. Microparticles from Patients Undergoing Percutaneous Coronary Intervention Impair Vasodilatation by Uncoupling Endothelial Nitric Oxide Synthase. Shock. 2017. PMID: 28002238. doi:10.1097/SHK.0000000000000823
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。